GRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The objective of the GRAVITAS trial is to determine whether tailored anti-platelet therapy
using the Accumetrics VerifyNow P2Y12 assay reduces major adverse cardiovascular events after
drug-eluting stent implantation.